Global Bivalirudin and desmopressin Market

Outlook: Industry Insights & Opportunity

Evaluation, 2017-2024

Copyright Research Nester Pvt. Ltd. www.researchnester.com

 Entering New Emerging Markets

Launch & Viability of Product

Competitive Analysis

Industry Analysis

Research Nester, currently serving clients from 120+ countries

clients across the globe, is a leading service provider for
strategic market research and consulting. We aim to provide
unbiased, unparalleled market insights and industry analysis to
help industries, conglomerates and executives to take wise
decisions for their future marketing strategy, expansion and
investment etc. We believe every business can expand to its new
horizon, provided a right guidance at a right time is available
through strategic minds. Our out of box thinking helps our
clients to take wise decision so as to avoid future uncertainties.
Through our robust, unbiased extensive primary and secondary
research, we help organizations to understand current and
future market trends, thus letting them making a prolonged yet
dynamic financial investment.
Copyright Research Nester Pvt. Ltd. www.researchnester.com
 Real Estate Food & Beverage

FMCG
Energy &
Power

Industries
Catered

Healthcare
ICT

Information Semiconductor
Technology
Copyright Research Nester Pvt. Ltd. www.researchnester.com
 Our Services

Data Data Research Actionable Business

Collection Analysis & Analysis Insight Solution

Primary Secondary Company

Research /Desk Analysis
Research

We Offer

In-depth Industry Analysis

Our exhaustive research reports are a combination of qualitative and quantitative data and
analysis
Research conducted using credible database and industry tools and primary insights
Unbiased and detailed analysis of financial statistics, competitors analysis
Market size estimation (by value and volume) and forecasting
Detailed mapping on SWOT Analysis, Porters Five Force Model Analysis, PESTEL Analysis

Custom Research Services

Tracking the market as per the industrys movement
Conducting interviews to portray real situations and industrys trends
In-depth analysis and information gathering as per clients requirement
Provide 360 degree approach reports to meet clients specific requirement

Market
Study of
Competition Channel Assessment Future Target
Developme Recommendation
Study Assessment /Estimation Share Market
nts
s/Forecast
Copyright Research Nester Pvt. Ltd. www.researchnester.com
 Sample Research Presentation Look for Your
Requested Research/TOC

Copyright Research Nester Pvt. Ltd. www.researchnester.com

 Global Bivalirudin & desmopressin Market
Final Deliverable Table of Content

Global Bivalirudin and desmopressin Market Overview

Bivalirudin is a thrombin inhibiting oligopeptide that was developed

through rational drug as a hirudin analogue. It is a thrombin inhibitor
consisting of 20 amino acid structure combining a carboxy-terminal
region that recognizes thrombins fibrin (ogen)- binding sate. It
works by blocking of the formation of blood clots. Likewise,
desmopressin is an antidiuretic harmone. It works by causing the
kidneys to produce less urine. Bivalirudin is used as an anticoagulant
in the patients with unstable angina who are undergoing percutaneous
transluminal coronary angioplasty (PTCA) and in patients undergoing
percutaneous coronary intervention (PCI). Moreover, Bivalirudin is
used in conjuction with other medicines. Further, desmopressin is
used to manage temporarily increased thirst and urination caused by
head injury.

Market Size and Forecast

The market is expected to increase significantly over the

forecast period 2017-2024. The bivalirudin is facing increased
demand due to its application in the treatment of coronary artery
disease and cancer. Likewise, the demand for desmopressin is
increasing due to its use in bedtime wetting and nocturia.

Copyright Research Nester Pvt. Ltd. www.researchnester.com

 Market Segmentation:

Our in depth analysis of the bivalirudin and desmopressin market

includes the following segments:

By Use:
Percutaneous Transluminal Coronary Angioplasty (PTCA) Procedures
Percutaneous Coronary Intervention (PCI) Procedures
Others

The global bivalirudin and desmopressin market is further classified

on the basis of region as follows:

By Region:
North America (U.S. & Canada) Market size, Y-O-Y growth &
Opportunity Analysis
Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-
O-Y growth & Opportunity Analysis
Western and Eastern Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, Rest of Western
Europe) Market size, Y-O-Y growth & Opportunity Analysis
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand,
Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.

Copyright Research Nester Pvt. Ltd. www.researchnester.com

Growth Drivers and Challenges

The market growth is driven by the rise in the number of the cases of
cardiovascular diseases. According to the American Heart Association,
the number of the adults living with the heart failure has increased
from 5.7 million (2009-12) to about 6.5 million (2011-2014). Further,
the cardiovascular diseases are on rise thereby leading to the increased
number of deaths across the world. The cardiovascular diseases
include coronary artery disease, high blood pressure and stroke. The
patients with ST-elevation myocardial infarction (STEMI) is often
achieved via primary percutaneous coronary intervention (PCI), thus
reducing major adverse cardiovascular diseases. Adjunctive
antithrombotic and antiplatelet therapies are used during PCI to
reduce MACE rates. The most commonly used agents include low
unfractioned heparin. These agents reduce the rates of peri-procedural
ischemic and thrombotic events, but these agents produce

Copyright Research Nester Pvt. Ltd. www.researchnester.com

complications in the form of increased bleeding, but bivalirudin has
emerged as a safe alternative to heparin and helps in reducing the risk
of coronary artery disease. Moreover, bivalirudin has advantages over
the heparin including reduced rates of mortality, cardiovascular
mortality and major bleeding events. Therefore, this has led to the
adoption of bivalirudin as a drug for the treatment of coronary artery
disease, thus leading to the expansion of the bivalirudin market. The
increase in the number of cancer patients is another reason that is
driving the growth of bivalirudin market. According to the World
Health Organization (WHO), approximately 14 million cases came
into the light in 2012. Moreover, the cancer is second leading cause of
the death globally, and was responsible for 8.8 million deaths in 2015.
The expansion of the desmopressin market is driven by the increasing
number of nocturia cases among elderly men and women. Nocturia is
a lower urinary tract symptom which involves the need for passing
urine at night, resulting in the disturbance of sleep. As a result, it
frequently impacts upon the quality of life (QoL) and wellbeing of
individuals. The prevalence increases with the age and has reported to
be as high as 77% and 94% in elderly women and men respectively,
thus leading to the expansion of the desmopressin market.
Desmopressin works as an effective treatment for patients with
nocturia. The antidiuretic effect of desmopressin decreases the
number of the night voids and prolongation of the sleep period as
compared to placebo. However, the market growth of Bivalirudin is

Copyright Research Nester Pvt. Ltd. www.researchnester.com

 hindered by various reasons including the cost and the reluctance to
change from existing anti-thrombotic agents used.

Key Players
Pfizer, Inc. (US)
o Company Overview
o Key Product Offerings
o Business Strategy
o SWOT Analysis
o Financials
Bayer Healthcare AG (Germany)
GlaxoSmithKline PLC. (UK)
Abott India Limited (India)
Mitsubishi Tanabe Pharma Corporation (Japan)
Sun Pharmaceuticals Industries Limited
Ferring Pharmaceuticals
Eisai Inc.
Boehringer Ingelheim
Sanofi S.A.

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

Copyright Research Nester Pvt. Ltd. www.researchnester.com

 The Global Bivalirudin and Desmopressin Market is segmented as
follows:
By Use Market Size & Y-O-Y Growth Analysis
By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porters Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and

Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current

dynamic environment

To know more about Bivalirudin & desmopressin

Market Research, please visit:
http://www.researchnester.com/reports/bivalirudin-and-desmopressin-
market-global-demand-analysis-opportunity-outlook-2024/266

Copyright Research Nester Pvt. Ltd. www.researchnester.com

Related Reports:

http://www.researchnester.com/reports/meningitis-vaccine-market-global-
demand-growth-analysis-opportunity-outlook-2023/231

http://www.researchnester.com/reports/dermatology-medical-device-
market-global-demand-growth-analysis-opportunity-outlook-2023/229

For More Info/Enquiry, Please Visit us at:

Research Nester Pvt. Ltd.

1820 Avenue M,
Suite #1113
Brooklyn, New York 11230

U.S. (T) +1 646 586 9123

Canada (T) +1 437 889 3230
U.K. (T) +44 203 608 5919
www.researchnester.com, info@researchnester.com

Copyright Research Nester Pvt. Ltd. www.researchnester.com